| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 6 | -594,776 | 100% | $64.84 | -$38,567,104 |
| Net | -6 | -594,776 | -100% | -$38,567,104 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Thilo Schroeder | Director | $349,650,002 | 05 Dec 2024 | ||
| Third Rock Ventures III, L.P. | 10%+ Owner | $137,811,510 | 08 Jun 2022 | ||
| Alexis Borisy | Director | $92,479,473 | 26 Jun 2025 | ||
| MARK A. GOLDSMITH | President and Chief Executive Officer, Director | $36,170,179 | -$16,965,203 | -32% | 01 Mar 2026 |
| Stephen Michael Kelsey | President, Research and Development | $28,765,206 | -$7,735,089 | -21% | 01 Mar 2026 |
| Margaret A. Horn | Chief Operating Officer | $15,563,444 | -$8,392,358 | -35% | 01 Mar 2026 |
| Jack Anders | Chief Financial Officer | $12,310,874 | -$2,926,729 | -19% | 01 Mar 2026 |
| Xiaolin Wang | EVP, Clinical Development | $11,332,646 | 01 Mar 2026 | ||
| Lin Wei | Chief Medical Officer | $9,928,075 | -$185,532 | -1.8% | 01 Mar 2026 |
| Jeff Cislini | General Counsel | $5,900,466 | -$2,362,192 | -29% | 01 Mar 2026 |
| Sandra Horning | Director | $3,818,535 | 26 Jun 2025 | ||
| Lorence H. Kim | Director | $2,889,978 | 26 Jun 2025 | ||
| ELIZABETH M. ANDERSON | Director | $2,228,175 | 04 Mar 2026 | ||
| Neil Exter | Director | $1,317,951 | 16 Jun 2022 | ||
| Flavia Borellini | Director | $989,448 | 26 Jun 2025 | ||
| Sushil Patel | Director | $912,978 | 26 Jun 2025 | ||
| Vincent A. Miller | Director | $641,250 | 22 Jun 2021 | ||
| Barbara Weber | Director | $627,413 | 08 Oct 2024 | ||
| ERIC THOMAS SCHMIDT | Director | $573,777 | 08 Jun 2023 | ||
| Frank Clyburn | Director | $385,040 | 26 Jun 2025 | ||
| Third Rock Ventures II, L.P. | 10%+ Owner | $348,975 | 03 Jun 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|